Exodus Point Capital Management, LP Acumen Pharmaceuticals, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 25,620 shares of ABOS stock, worth $58,157. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,620Holding current value
$58,157% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABOS
# of Institutions
84Shares Held
26.8MCall Options Held
319KPut Options Held
86.3K-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$7.76 Million4.42% of portfolio
-
Franklin Resources Inc San Mateo, CA3.4MShares$7.71 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.63MShares$5.97 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$5.22 Million0.24% of portfolio
-
Laurion Capital Management LP New York, NY1.9MShares$4.3 Million0.07% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $91.9M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...